Salveen Richter - New York, New York, United States - LinkedIn
Location: New York · 500+ connections on LinkedIn. View Salveen Richter’s profile on LinkedIn, a professional community of 1 billion members.Connections: 500+Salveen Richter - Analyst at Goldman Sachs - Stock Analysis
Salveen Richter is a Wall Street analyst working for Goldman Sachs. Salveen has covered 43 stocks with a 41.67% success rate and an average return of 0.47%.
Salveen Richter | Goldman Sachs Stock Analyst - TipRanks.com
Jan 15, 2025 · Salveen Richter is a 4.41-star Wall Street Analyst at Goldman Sachs. Salveen Richter's focuses on the Healthcare sector and covers 84 stocks with a 40.86% success rate.
Is Big Pharma About To Win? Goldman Sachs Weighs In On 340B …
19 hours ago · Goldman Sachs analyst Salveen Richter highlights potential benefits for biopharma from 340B reforms, while Medicaid cuts could pose risks for companies with significant drug …
Leadership - Johns Hopkins Biomedical Engineering
Learn more about the Department of Biomedical Engineering leadership team, including faculty and advisory board members.
Salveen Richter - Stock Analyst - Performance Displayed - AnaChart
Jan 14, 2025 · Analyst Salveen Richter, currently employed at GOLDMAN SACHS, carries an average stock price target met ratio of 65.4% that have a potential upside of 34.24% achieved …
Gene Editing: The Future of Genomic Medicine
Mar 23, 2022 · In the latest episode of Exchanges at Goldman Sachs, Salveen Richter, Lead Analyst for the U.S. Biotechnology Sector in Goldman Sachs Research, explains how new innovations in gene editing are transforming the …
Salveen Richter's Stock Ratings - Benzinga
Salveen Richter is an analyst at Goldman Sachs. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected...
Goldman Sachs Reaffirms Their Buy Rating on Agios Pharma (AGIO)
Jan 3, 2024 · Goldman Sachs analyst Salveen Richter maintained a Buy rating on Agios Pharma (AGIO – Research Report) today. The company’s shares opened today at $23.58. According …
Mar 23, 2022 · So I've asked Salveen Richter, our lead biotechnology research analyst in the US, to join us to walk through the latest developments, the most promising applications, and the …
Related searches for salveen richter
